Home Tags Boehringer Ingelheim

Tag: Boehringer Ingelheim

Next Generation Immunotherapies

The immune system has already provided a number of potent strategies for treating cancers that are already impacting clinic, which in turn has stimulated...

Bi-specific Nanobody Strongly Inhibits Proliferation and Survival of Human Endothelial Cells...

Earlier this week positive in vivo proof-of-mechanism data from the half-life extended bi-specific anti-VEGF/Ang2 Nanobody, was presented at the 8th Euro Global Summit on Cancer Therapy, taking...